Bill > S552

This bill aims to promote transparency in prescription drug prices. Key provisions include: 1. The Health Policy Commission and Center for Health Information and Analysis will annually identify up to 15 prescription drugs with significant cost increases, and the Attorney General will require the drug manufacturers to justify these price increases. The Attorney General will then publish an annual report on the information received from the manufacturers. 2. Prescription drug manufacturers must submit a report to the Health Policy Commission 30 days prior to any price increase of 10% or more over 12 months, or the introduction of a new drug that may significantly impact costs. The report must include detailed information on the price increase, drug development costs, profits, and other factors. 3. The existing law requiring the Health Policy Commission to hold public hearings on health care cost trends is amended to specifically include testimony from prescription drug manufacturers whose drugs were identified in the Attorney General's annual report. The overall goal is to increase transparency around prescription drug pricing and costs, in order to better understand the factors driving price increases and their impact on the healthcare system.

Business and Industry

https://malegislature.gov/Bills/191/S552